Navigation Links
The Logic Behind The Spread Of SARS

Hong Kong was the hardest-hit area during the worldwide epidemic with the highest incidence rate and a high fatality rate. In 2003, Hong Kong had // 1,755 SARS cases and 299 deaths in a population of 6.7 million.

A recent study explains the large community outbreak of SARS in Hong Kong. It seems the air may be to blame. Investigators say, for future prevention and control, health care professionals must take the potential for airborne spread of the virus into consideration.

Researchers examined the initial 187 cases of Severe Acute Respiratory Syndrome in China. They found residents on middle and upper floors of the building in which 99 SARS patients lived were at a significantly higher risk than residents on lower floors. This finding is consistent with the rising of contaminated warm air in the air shaft generated from a middle-level apartment unit in that building. Investigators say the contaminated air at the top of the air shaft was then carried toward the other buildings by a northeasterly wind. All but five of the initial patients lived in the seven buildings of the complex.

Management and security staff of the complex who worked on the ground floor in each building would probably have had frequent person-to-person contact with residents, but they were not affected by the virus. Coupled with the finding of much lower concentrations of the virus in respiratory secretions than in urine and stool, researchers conclude the spread was not initiated by respiratory means but by virus-laden aerosols spread through dried up seals in a bathroom and passed on by an exhaust fan.
'"/>




Page: 1

Related medicine news :

1. You Can Be Emotional And Logical
2. Fizzy Logic For A Perfect Drink: Courtesy Boffins
3. Understanding The Mystery Behind Sleepless Nights
4. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
5. Researchers Find Out The Cause Of Immune Attacks Behind Hearing Loss
6. Molecule Behind Multiple Sclerosis Discovered
7. Annual Dental Checkups in Children Lagging Behind
8. Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolvd
9. NHS Says Government Advice Behind Refusal of Cancer Drug
10. Know The Brain Behind The Human Growth Hormone!
11. Vital Facts of Short Term Diets - Catch The Vitamin Behind An Ample Waist!
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Logic Behind The Spread SARS

(Date:5/16/2008)...ns of Children Still in Danger, NEW YORK, May 16 ...dvertising Council today announced a partnership t...ic service announcements (PSAs) filmed by A-List,c... Joel Madden, David,Duchovny, Tea Leoni, and Paul ...r cyclone. The Ad Council is distributing the new ...
(Date:5/16/2008)...wswire-FirstCall/ -- Nationwide,Health Properties,...of David,M. Boitano to Senior Vice President and S...ous contribution to NHP over the last several year... diversification strategy,successes. Dave has been...stments for NHP, leveraging his vast experience an...
(Date:5/16/2008)...Call/ -- CryoCor, Inc. (Nasdaq:,CRYO), a medical d...arrhythmias, announced today that on May 8, 2008, ...a complaint in the Superior Court of the State,of ...nts each member of the,Board of Directors of CryoC... complaint is styled Secondido, et al. v. CryoCor,...
(Date:5/16/2008)...ed to community physicians, audit finds , ...s between major academic cancer centers and commun...ead cancer treatment advances, say researchers at ... new cancer treatments are created at major academ...munity hospitals, noted the researchers, who condu...
Breaking Medicine News(10 mins):Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 2Health News:Video: The Ad Council Partners With UNICEF to Promote and Distribute Myanmar Cyclone PSAs Filmed by A-List Celebrities 3Health News:David M. Boitano Promoted to Senior Vice President 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4Health News:Partnerships Effective Communicators of Cancer Advances 2
...th crisis in the Palestinian territory following t...he UN health agency has called for urgent action b...n of basic medical services. "The crisis is seriou...tinian Ministry of Health to deliver critical heal...
...apathy, has been appointed honorary consultant and...vices in speciality of plastic, hand and reconstru...ead of the Department of surgery in Ganga Medical ...consultation and perform major operations to membe...
...od protein levels are found to be associated with ...es// , metabolic syndrome and cardiovascular disea...inding protein 4 (RBP4), when reduced by the effec...s proved to drop the risk factors of diabetes – fi...
...issioned by The Globe and Mail and CTV News it is ...rans fats that are among the highest in the world/...When surveyed the different outlets of fast foods ...it was found that the amount of trans fat in these...
Other Medicine News:Health News:A Carrier Protein Associates With Human Insulin Resistance 2
(Date:5/15/2008)...May 15 /- Medivation, Inc.,... ongoing Phase 1-2 clinical,trial of its novel and...ted,in an oral presentation at the 44th American S...in Chicago., Session title: New Targeted Strate...te and time: Monday, June 2 at 11:30 a.m. Central ...
(Date:5/15/2008)...ed amount of research reflects depth and breadth o...develop new treatments for ...hlight impact of Zometa(R), the leading IV, bispho...tage breast cancer, - Four oral sessions to featu...itor of mTOR, including first results of RECORD-1 ...
(Date:5/15/2008).... and TOULOUSE, France, May 15 /- Cer...harmaceutical company,developing HDL-related compo...olic diseases, today announced that it has complet...e company,s lead product candidates.,CER-002 is a ...delta-specific agonist in development for the trea...
(Date:5/15/2008)...unity Remains for an Antiplatelet Therapy that, Co...e Combination of Plavix/Iscover and Aspirin, A... WALTHAM, Mass., May 15 /- Decision R...advisory firms for pharmaceutical and,healthcare i...nt offers,improvement in patient compared to Sanof...
Breaking Medicine Technology:Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 2Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3Coley Pharmaceutical Group Adopts Shareholder Rights Plan 1116 1Coley Pharmaceutical Group Adopts Shareholder Rights Plan 1116 2Coley Pharmaceutical Group Adopts Shareholder Rights Plan 1116 3Enrollment Complete in Pivotal Phase 3 Trial of Medidur 28TM 29 FA for Diabetic Macular Edema 462 1Enrollment Complete in Pivotal Phase 3 Trial of Medidur 28TM 29 FA for Diabetic Macular Edema 462 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur 28TM 29 FA for Diabetic Macular Edema 462 3Enrollment Complete in Pivotal Phase 3 Trial of Medidur 28TM 29 FA for Diabetic Macular Edema 462 4American Chemical Societys Weekly PressPac Oct 3 2007 709 1American Chemical Societys Weekly PressPac Oct 3 2007 709 2American Chemical Societys Weekly PressPac Oct 3 2007 709 3American Chemical Societys Weekly PressPac Oct 3 2007 709 4American Chemical Societys Weekly PressPac Oct 3 2007 709 5American Chemical Societys Weekly PressPac Oct 3 2007 709 6American Chemical Societys Weekly PressPac Oct 3 2007 709 7American Chemical Societys Weekly PressPac Oct 3 2007 709 8Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 1Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 2Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 3Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 4Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 5Mylan Inc Subsidiary Dey L P Announces that Perforomist 28TM 29 28Formoterol Fumarate 29 Inhalation Solution is Now Available for Maintenance Tr 1113 6
Aaron manufactures two groups of flexible lighting products. The first is available both sterile and non-sterile in three different sizes 5", 10", and 15" (refers to the flexible shaft portion of the
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include
...des of Operation: , Standby: A standby switch main...timulus pulses. , Double Burst : 2 60-ms bursts of...itch: 1 s (1 pulse/s); 2 Hz (2 pulses/s) , Tetanu...Train-Of-Four: 4 pulses/2 s; repeats every 10 s , ...
Medicine Products: